Watanabe Todd Franklin
Arcutis Biotherapeutics, Inc. - Common stock · See Remarks
Watanabe Todd Franklin is listed in filings as See Remarks at Arcutis Biotherapeutics, Inc. - Common stock. This profile follows SEC Form 4 activity through Jun 12, 2025, including sale activity and purchase activity. Recent filings connect the profile to Arcutis Biotherapeutics, Inc. - Common stock (ARQT). The current snapshot covers public activity from Aug 5, 2024 to Jun 12, 2025. Reported amounts are shown as $173.9K to $26.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $38k2.2k shares | SellMar 25, 2025 | $17.56 | $21.15 | |
| $26k1.5k shares | SellMar 24, 2025 | $17.52 | $21.15 | |
| $21k1.2k shares | SellMar 17, 2025 | $17.61 | $21.15 | |
| $55k4.1k shares | SellMar 4, 2025 | $13.28 | $21.15 | |
| $272k20.9k shares | SellMar 3, 2025 | $13.03 | $21.15 | |
| $245k19.3k shares | SellFeb 3, 2025 | $12.70 | $21.15 | |
| $228k15k shares | SellDec 20, 2024 | $15.17 | $21.15 | |
| $14k2k shares | BuyNov 30, 2024 | $7.11 | $21.15 | |
| $120k13.9k shares | SellNov 4, 2024 | $8.68 | $21.15 | |
| $131k14.5k shares | SellAug 2, 2024 | $9.02 | $21.15 |